Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.
How did TECH's recent EPS compare to expectations?
The most recent EPS for Bio-Techne Corp is $, expectations of $0.52.
How did Bio-Techne Corp TECH's revenue perform in the last quarter?
Bio-Techne Corp revenue for the last quarter is $
What is the revenue estimate for Bio-Techne Corp?
According to 11 of Wall street analyst, the revenue estimate of Bio-Techne Corp range from $309.33M to $281.36M
What's the earning quality score for Bio-Techne Corp?
Bio-Techne Corp has a earning quality score of B+/48.002537. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Bio-Techne Corp report earnings?
Bio-Techne Corp next earnings report is expected in 2026-11-09
What are Bio-Techne Corp's expected earnings?
Bio-Techne Corp expected earnings is $320.97M, according to wall-street analysts.
Did Bio-Techne Corp beat earnings expectations?
Bio-Techne Corp recent earnings of $ expectations.